Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2024. Start Trial.
Date Value
November 09, 2026 1.384
November 06, 2026 1.333
November 05, 2026 1.371
November 04, 2026 1.480
November 03, 2026 1.502
November 02, 2026 1.520
October 30, 2026 1.634
October 29, 2026 1.684
October 28, 2026 1.760
October 27, 2026 1.708
October 26, 2026 1.666
October 23, 2026 1.672
October 22, 2026 1.716
October 21, 2026 1.835
October 20, 2026 1.841
October 19, 2026 1.646
October 16, 2026 1.539
October 15, 2026 1.609
October 14, 2026 1.596
October 13, 2026 1.655
October 12, 2026 1.731
October 09, 2026 2.067
October 08, 2026 2.071
October 07, 2026 2.099
October 06, 2026 2.143
Date Value
October 05, 2026 2.204
October 02, 2026 2.137
October 01, 2026 2.048
September 30, 2026 2.063
September 29, 2026 2.085
September 28, 2026 2.120
September 25, 2026 2.094
September 24, 2026 2.097
September 23, 2026 2.056
September 22, 2026 2.155
September 21, 2026 2.174
September 18, 2026 2.241
September 17, 2026 2.133
September 16, 2026 1.929
September 15, 2026 1.917
September 14, 2026 1.959
September 11, 2026 1.882
September 10, 2026 1.937
September 09, 2026 2.063
September 08, 2026 2.094
September 04, 2026 2.136
September 03, 2026 2.213
September 02, 2026 2.089
September 01, 2026 1.997
August 31, 2026 1.937

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Intellia Therapeutics, Inc. 2.770
Twist Bioscience Corp. 19.03
Natera, Inc. 24.74
Veracyte, Inc. 1.459
CareDx, Inc. 9.474

Price to Book Value Related Metrics

Price 10.57
Earnings Yield -0.66%
Market Cap 109.01M